World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
56926
World Ranking
11494
National Ranking
338

Kazuo Fujihara publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Kazuo Fujihara sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 465 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Kazuo Fujihara D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Kazuo Fujihara sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Kazuo Fujihara is affiliated with Fukushima Medical University in Japan. Their research primarily focuses on fields within medicine, including pathology and forensic medicine, neurology, rheumatology, immunology, and molecular biology.

The main topics of their work include multiple sclerosis research studies, peripheral neuropathies and disorders, systemic lupus erythematosus research, neuroinflammation and neurodegeneration mechanisms, systemic sclerosis and related diseases, CNS lymphoma diagnosis and treatment, and protein tyrosine phosphatases.

Frequent publication venues for Kazuo Fujihara include:

  • Neurology
  • Multiple Sclerosis and Related Disorders
  • Journal of the Neurological Sciences
  • The Lancet Neurology
  • Frontiers in Neurology

Frequently collaborating co-authors include:

  • Ichiro Nakashima
  • Tatsuro Misu
  • Masashi Aoki
  • Dean M. Wingerchuk
  • Sean J. Pittock

Recent papers by Kazuo Fujihara include:

  • "Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology" (2020, Neurology Neuroimmunology & Neuroinflammation)
  • "Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria" (2023, The Lancet Neurology)
  • "Myelin-oligodendrocyte glycoprotein antibody-associated disease" (2021, The Lancet Neurology)
  • "Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide" (2020, Frontiers in Neurology)
  • "Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study" (2020, Brain)

Best Publications

  • Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

    Chris H Polman;Stephen C Reingold;Brenda Banwell;Michel Clanet

  • Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

    Alan J. Thompson;Brenda L. Banwell;Frederik Barkhof;Frederik Barkhof;William M. Carroll

  • International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

    Dean M. Wingerchuk;Brenda Banwell;Jeffrey L. Bennett;Philippe Cabre

  • A serum autoantibody marker of neuromyelitis optica : distinction from multiple sclerosis

    Vanda A Lennon;Dean M Wingerchuk;Thomas J Kryzer;Sean J Pittock

  • Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

    Douglas Kazutoshi Sato;Dagoberto Callegaro;Marco Aurelio Lana-Peixoto;Patrick J. Waters

  • Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder

    Sean J Pittock;Achim Berthele;Kazuo Fujihara;Kazuo Fujihara;Ho Jin Kim

  • Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

    Toshiyuki Takahashi;Kazuo Fujihara;Ichiro Nakashima;Tatsuro Misu

  • MOG encephalomyelitis: International recommendations on diagnosis and antibody testing

    S. Jarius;F. Paul;F. Paul;O. Aktas;N. Asgari

  • Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.

    T. Misu;K. Fujihara;A. Kakita;H. Konno

  • Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.

    Monika Bradl;Tatsuro Misu;Toshiyuki Takahashi;Mitsutoshi Watanabe

  • MRI characteristics of neuromyelitis optica spectrum disorder An international update

    Ho Jin Kim;Friedemann Paul;Marco A. Lana-Peixoto;Silvia Tenembaum

  • Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.

    Bruce A C Cree;Jeffrey L Bennett;Ho Jin Kim;Brian G Weinshenker

  • Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan

    J Kitley;M I Leite;I Nakashima;P Waters

  • Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder

    Takashi Yamamura;Ingo Kleiter;Kazuo Fujihara;Jacqueline Palace

  • MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy

    Ryo Ogawa;Ichiro Nakashima;Toshiyuki Takahashi;Kimihiko Kaneko

  • The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.

    Claudia F. Lucchinetti;Yong Guo;Bogdan F. Gh. Popescu;Bogdan F. Gh. Popescu;Kazuo Fujihara

  • Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica

    T. Misu;K. Fujihara;I. Nakashima;S. Sato

  • MOG cell-based assay detects non-MS patients with inflammatory neurologic disease

    P Waters;M Woodhall;K C O'Connor;M Reindl

  • Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO : a study on antibody titre. Commentary

    Alastair Compston;Toshiyuki Takahashi;Kazuo Fujihara;Ichiro Nakashima

  • MOG-Enzephalomyelitis: Internationale Empfehlungen zu Diagnose und Antikörpertestung [MOG encephalomyelitis: international recommendations on diagnosis and antibody testing]

    S. Jarius;F. Paul;O. Aktas;N. Asgari

Frequent Co-Authors

Ichiro Nakashima
Ichiro Nakashima Tohoku Medical and Pharmaceutical University
Yasuto Itoyama
Yasuto Itoyama Tohoku University
Michael J. Levy
Michael J. Levy Harvard Medical School
Sean J. Pittock
Sean J. Pittock Mayo Clinic
Friedemann Paul
Friedemann Paul Charité - University Medicine Berlin
Hans Lassmann
Hans Lassmann Medical University of Vienna
Markus Reindl
Markus Reindl Innsbruck Medical University
Patrick Waters
Patrick Waters University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in a medical career but aren’t ready for medical school, there are many alternative pathways to consider. Many students are looking for flexible, accessible programs that can jumpstart their careers in healthcare from home.

For those drawn to nursing, there are easiest BSN program to get into options that offer less competitive admissions processes. Some colleges also have nursing programs without TEAS or entrance exam requirements, making it easier for aspiring nurses to begin their studies.

Individuals without a prior nursing background may be interested in online direct entry MSN programs designed to fast-track non-nurses into advanced nursing roles. These programs are intensive yet allow for career changes or upskilling without the traditional timeline.

Healthcare administration and medical office roles are also in high demand. For a non-clinical track, you can explore medical billing and coding online schools that accept financial aid. This is a great way to enter the healthcare field with needed skills and flexible study arrangements.

Best Scientists Citing Kazuo Fujihara

Trending Scientists

Recently Published Articles